Independent confirmation with a single-cell RNA sequencing dataset of normal and CRC tumor samples [30] revealed a significant decrease in BCL-2 and concomitant increase in BCL-XL, specifically in the epithelial tumor compartment (Fig. 5e, f). The gene discussed is BCL2L1; the disease is neoplasm.